NCT02147613

Brief Summary

Heart failure is a major health concern and is the leading cause of hospitalization among elderly Americans. Currently 5.7 million Americans are estimated to have heart failure and the estimated direct and indirect costs of treating heart failure are approximately $37.2 billion. Approximately 40% of those diagnosed with heart failure will have heart failure with preserved ejection fraction (HFPEF). These individuals have significant restrictions in their ability to carry out activities of daily living. Exercise training has been established as adjuvant therapy in heart failure. Although exercise training guidelines for treatment of heart failure with reduced ejection fraction (HFREF) are well established, no consensus exercise guidelines exist for management of HFPEF. Aerobic and cardiovascular adaptations are generally greater after high-intensity exercise training; interval-type exercise facilitates this type of training because it allows for rest periods that make it possible for patients with heart failure to perform short (e.g., 1-4 minutes) work periods at intensities that are higher than would be possible during continuous exercise. High-intensity aerobic interval training presents a unique, yet untested, therapeutic modality for the exercise training of patients with heart failure with preserved ejection fraction. Pilot testing is warranted, results of which may have important implications for reducing cardiovascular risk, increasing short- and long-term quality of life and survival, and reducing healthcare costs in this patient population. The investigators primary specific aim is to determine the efficacy of a novel, high-intensity aerobic interval exercise training program for improving VO2peak (peak oxygen uptake), endothelial function, and arterial stiffness in patients with HFPEF. The investigators secondary aim is to determine whether the vascular changes are correlated with the changes in VO2peak.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2010

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 28, 2014

Completed
4.9 years until next milestone

Results Posted

Study results publicly available

April 12, 2019

Completed
Last Updated

April 12, 2019

Status Verified

January 1, 2019

Enrollment Period

1.4 years

First QC Date

May 21, 2014

Results QC Date

October 5, 2017

Last Update Submit

April 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Left Ventricular Diastolic Dysfunction

    Measured using left ventricular echocardiography. Diastolic dysfunction is graded as: normal, grade 1, grade 2, grade 3, grade 4. Increasing grade is indicative of worsening LV dysfunction and worse outcomes. Improvement in LV grade is associated with better long term outcomes.

    Before and after the 1 month exercise intervention

Secondary Outcomes (1)

  • VO2peak

    Test carried out before and after the 1 month long exercise intervention.

Other Outcomes (1)

  • Brachial Artery Flow-mediated Dilation

    Before and after 1-month exercise intervention

Study Arms (2)

High intensity interval training

EXPERIMENTAL

High intensity interval training - 3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)

Other: High intensity interval training

Moderate intensity exercise training

ACTIVE COMPARATOR

3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)

Other: Moderate intensity exercise training

Interventions

3 days per week at 85-90% peak heart rate (4x4 bouts) for 1 month (12 sessions of exercise)

High intensity interval training

3 days/week, 30 mins at 70% Peak heart rate for 1 month (12 sessions of exercise)

Moderate intensity exercise training

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HFpEF diagnosis with New York Heart Association heart failure Class II-III symptoms

You may not qualify if:

  • Unstable angina
  • Myocardial infarction in the past 4 weeks
  • Uncompensated heart failure
  • New York Heart Association class IV symptoms
  • Complex ventricular arrhythmias (at rest or during the maximal exercise test)
  • Medical or orthopedic conditions that precluded treadmill walking
  • Symptomatic severe aortic stenosis
  • Acute pulmonary embolus
  • Acute myocarditis
  • Medication non-compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Arizona State University

Phoenix, Arizona, 85004, United States

Location

Mayo Clinic

Scottsdale, Arizona, 85259, United States

Location

Related Publications (1)

  • Angadi SS, Mookadam F, Lee CD, Tucker WJ, Haykowsky MJ, Gaesser GA. High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. J Appl Physiol (1985). 2015 Sep 15;119(6):753-8. doi: 10.1152/japplphysiol.00518.2014. Epub 2014 Sep 4.

MeSH Terms

Conditions

Heart Failure, Diastolic

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Heart FailureHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Siddhartha S. Angadi, PhD., FACSM
Organization
Arizona State University - Downtown Phoenix Campus

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2014

First Posted

May 28, 2014

Study Start

November 1, 2010

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

April 12, 2019

Results First Posted

April 12, 2019

Record last verified: 2019-01

Locations